Literature DB >> 16916947

Metabolic activation of glucose low-responsive beta-cells by glyceraldehyde correlates with their biosynthetic activation in lower glucose concentration range but not at high glucose.

G A Martens1, Q Wang, K Kerckhofs, G Stangé, Z Ling, D Pipeleers.   

Abstract

Insulin synthesis and release activities of beta-cells can be acutely regulated by glucose through its glycolytic and mitochondrial breakdown involving a glucokinase-dependent rate-limiting step. Isolated beta-cell populations are composed of cells with intercellular differences in acute glucose responsiveness that have been attributed to differences in glucokinase (GK) expression and activity. This study first shows that glyceraldehyde can be used as GK-bypassing oxidative substrate and then examines whether the triose can metabolically activate beta-cells with low glucose responsiveness. Glyceraldehyde 1 mm induced a similar cellular (14)CO(2) output and metabolic redox state as glucose 4 mM. Using flow cytometric analysis, glyceraldehyde (0.25-2 mM) was shown to concentration-dependently increase the percent metabolically activated cells at all tested glucose concentrations (2.5-20 mM). Its ability to activate beta-cells that are unresponsive to the prevailing glucose level was further illustrated in glucose low-responsive cells that were isolated by flow sorting. Metabolic activation by glyceraldehyde was associated with an activation of nutrient-driven translational control proteins and an increased protein synthetic response to glucose, however not beyond the maximal rates that are inducible by glucose alone. It is concluded that glucose low-responsive beta-cells can be metabolically activated by the GK-bypassing glyceraldehyde, increasing their acute biosynthetic response to glucose but not their maximal glucose-inducible biosynthetic capacity, which is considered subject to chronic regulation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16916947     DOI: 10.1210/en.2006-0580

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  5 in total

1.  Protein markers for insulin-producing beta cells with higher glucose sensitivity.

Authors:  Geert A Martens; Lei Jiang; Katrijn Verhaeghen; Joanne B Connolly; Scott G Geromanos; Geert Stangé; Laurence Van Oudenhove; Bart Devreese; Karine H Hellemans; Zhidong Ling; Christiaan Van Schravendijk; Daniel G Pipeleers; Johannes P C Vissers; Frans K Gorus
Journal:  PLoS One       Date:  2010-12-06       Impact factor: 3.240

2.  Subpopulations of GFP-marked mouse pancreatic β-cells differ in size, granularity, and insulin secretion.

Authors:  Hitoshi Katsuta; Cristina Aguayo-Mazzucato; Rimiko Katsuta; Tomoyuki Akashi; Jennifer Hollister-Lock; Arun J Sharma; Susan Bonner-Weir; Gordon C Weir
Journal:  Endocrinology       Date:  2012-08-23       Impact factor: 4.736

3.  Glibenclamide activates translation in rat pancreatic beta cells through calcium-dependent mTOR, PKA and MEK signalling pathways.

Authors:  Q Wang; H Heimberg; D Pipeleers; Z Ling
Journal:  Diabetologia       Date:  2008-05-21       Impact factor: 10.122

Review 4.  Pancreatic β-cell heterogeneity in health and diabetes: classes, sources, and subtypes.

Authors:  Mario A Miranda; Juan F Macias-Velasco; Heather A Lawson
Journal:  Am J Physiol Endocrinol Metab       Date:  2021-02-15       Impact factor: 4.310

Review 5.  Heterogeneity in the Beta-Cell Population: a Guided Search Into Its Significance in Pancreas and in Implants.

Authors:  Daniel Pipeleers; Ines De Mesmaeker; Thomas Robert; Freya Van Hulle
Journal:  Curr Diab Rep       Date:  2017-08-15       Impact factor: 4.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.